🇺🇸 FDA
Patent

US 8211649

Methods of diagnosing and prognosing hodgkin's lymphoma

granted A61KA61K51/088A61K51/1021

Quick answer

US patent 8211649 (Methods of diagnosing and prognosing hodgkin's lymphoma) held by The Board of Regents of the University of Texas System expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K51/088, A61K51/1021